Hubert Walinski
Direttore/Membro del Consiglio presso CIPHER PHARMACEUTICALS INC.
Patrimonio netto: - $ in data 30/04/2024
Profilo
Hubert Walinski is currently an Independent Director at Cipher Pharmaceuticals, Inc. and the Chief Scientific Officer at Aic Global Holdings, Inc. Previously, he worked as the Head-Medical Respiratory, Immunology & Vaccines at AstraZeneca Canada, Inc. Mr. Walinski holds a doctorate degree from the University of British Columbia, which he obtained in 2007.
He also has an undergraduate degree from McMaster University, which he received in 2001.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 22/06/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Posizioni attive di Hubert Walinski
| Società | Posizione | Inizio |
|---|---|---|
| CIPHER PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 21/06/2023 |
| Aic Global Holdings, Inc. | Direttore Tecnico/Scientifico/R&S | 01/08/2021 |
Precedenti posizioni note di Hubert Walinski
| Società | Posizione | Fine |
|---|---|---|
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Direttore Tecnico/Scientifico/R&S | 01/07/2021 |
Formazione di Hubert Walinski
| University of British Columbia | Doctorate Degree |
| McMaster University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CIPHER PHARMACEUTICALS INC. | Health Technology |
| Aziende private | 2 |
|---|---|
| Aic Global Holdings, Inc. | |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Health Technology |
- Borsa valori
- Insiders
- Hubert Walinski
